NCT07346261Not yet recruiting
Digital High-Intensity Respiratory Muscle Training on COPD Patients
Impact of Digital High-Intensity Respiratory Muscle Training on Ventilatory Function and Functional Capacity in Patients With COPD
Source: ClinicalTrials.gov · Last updated 21 Jan 2026
Brief summary (registry, in English)
The goal of this Randomize control trail is to determine the effect of Digital High-Intensity Respiratory Muscle Training on ventilatory Function and Functional Capacity in Patients with COPD It will also learn about the safety and tolerability of this digital training program. The main questions it aims to answer are: Does digital high-intensity respiratory muscle training improve inspiratory and expiratory muscle strength (MIP and MEP)? ,Does it improve functional exercise capacity (6-minute walk distance) and lung function (FEV₁, FVC, FEV₁/FVC)?
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 15 Jan 2026
- Start date
- 20 Jan 2026
- Primary completion date
- 20 Mar 2026
- Lead sponsor
- Cairo University
- Diseases
- COPD
- NCT number
- NCT07346261
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 20 Jan 2026 to the primary completion date, 20 Mar 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe comorbidities (e.g., coronary heart disease, arterial aneurysm, severe hepatic or renal dysfunction, uncontrolled hypertension).
- Unstable medical conditions or other respiratory diseases that could cause or contribute to breathlessness (e.g., asthma, pneumonia, bronchiectasis, tuberculosis, interstitial lung disease).
- Mental illness, deafness, limb activity disorder, or any condition causing inability to cooperate with procedures.
- Cognitive impairment or psychiatric illness that affects cooperation.
Other
- Participation in another clinical trial or intervention within the last 3 months.
- Current use of any other respiratory muscle training device or app.
Who the study is looking for
- Clinical diagnosis of chronic obstructive pulmonary disease (COPD), moderate to severe (GOLD stage II-IV)
- FEV₁ \> 80% of predicted.
- Age 50-65 years.
- Able to perform high-intensity respiratory muscle training (MIP and MEP ≥ device threshold).
- Clinically stable with no acute exacerbations.
Age in the registry: 50 years to 60 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.